Mo1890 Safety, Tolerability and Efficacy of E6011, Anti-Human Fractalkine Monoclonal Antibody, in the First-in-Patient Study for Crohn's Disease
Katsuyoshi Matsuoka(National Center For Child Health and Development), Takanori Kanai∥(Keio University), Toshiyuki Matsui(Fukuoka University), Takayuki Matsumoto(Kyushu University of Medical Science), Hiroko Nebiki, Kiyoshi Oketani, Kazuya Kitamura(Kyoto Prefectural University of Medicine), Makoto Naganuma, Hirohito Tsubouchi(Kagoshima University), Toshifumi Hibi∥(Kitasato Institute Hospital), Toshio Imai(Shionogi (Japan)), Fukunori Kinjo, Hideto Akama, Masayuki Saruta, Keiichi Mitsuyama(Kurume University), Masaki Iimuro, Motohiro Esaki(Kumamoto University), Satoshi Tanida, Noriyuki Horiki, Seiichiro Hojo, Mikihiro Fujiya, Makoto Arai(Tokyo Metropolitan Institute of Medical Science)
Cited by 3
Related Papers
Identification and Molecular Characterization of Fractalkine Receptor CX3CR1, which Mediates Both Leukocyte Migration and Adhesion
|Cell|1997|1.5k
Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis
|Gastroenterology|2013|938
Improving polygenic prediction in ancestrally diverse populations
|Nature Genetics|2022|714
Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer
|Digestive Endoscopy|2015|575
Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma
|European Journal of Cancer|2011|573